Dasatinib 70748-0210-07
- Manufacturer
- Lupin Pharmaceuticals, Inc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- January 30, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA214350
Need to source Dasatinib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dasatinib | 70 mg/1 |
Drug Class
Cytochrome P450 3A4 Inhibitors [MoA]Kinase Inhibitor [EPC]Protein Kinase Inhibitors [MoA]
Selected Package
70748-0210-07Selected1 BOTTLE in 1 CARTON (70748-210-07) / 60 TABLET in 1 BOTTLE